| Literature DB >> 32330196 |
Fangyan Jiang1,2, Hai Huang1,2, Ning Yang3, Huimin Feng1, Yu Li3, Bingbing Han3.
Abstract
Tail rot disease is associated with major economic losses in the seahorse aquaculture in China. This study aimed to isolate and identify the pathogen causing tail rot disease in seahorses. Three culturable intestinal bacteria strains were isolated from Hippocampus kuda specimens with tail rot disease. Strain HL11, HL12, and HL13 were identified as Pseudoalteromonas spongiae, Bacillus subtilis and Photobacterium ganghwense based on its morphological characteristics, physiological and biochemical properties, through 16S rRNA and gyrB sequencing, respectively. Challenge experiments using these strains on healthy H. kuda and bacterial re-isolation from challenged diseased seahorses showed that the bacteria strain named HL11 induced identical pathological symptoms, indicating that it is the causative pathogen of the disease. Antibiotic-resistance tests against of 32 antibiotics revealed that HL11 was highly sensitive to 13 kinds, while exhibited intermediate susceptibility to 6, and resistance to 13 kinds. Antibacterial tests of the bioactive agents showed that HL11 was susceptible to five kinds, including tea polyphenols, lactic acid, gallic acid, allicin, and polylysine; however, it was not susceptible to the other 13 kinds of bioactive agents. The results demonstrate the potential of using bioactive agents to replace antibiotics to generate an environmentally friendly mode of culturing seahorses.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32330196 PMCID: PMC7182253 DOI: 10.1371/journal.pone.0232162
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The clinical symptoms of H. kuda with tail rot disease.
The arrow meant that grayish-white patches on the tail of seahorse.
Physiological and biochemical properties of three isolates.
| Characteristic | HL11 | HL12 | HL13 | |||
|---|---|---|---|---|---|---|
| Motility | - | - | + | + | + | + |
| Oxidase | + | + | + | + | + | + |
| Ornithine decarboxylase | - | - | - | - | - | - |
| Lysine decarboxylase | + | - | - | - | - | + |
| Arginine dihydrolase | - | - | + | + | + | + |
| Urease | - | - | + | + | - | - |
| H2S production | + | + | - | - | - | - |
| Indole production | - | - | - | - | - | + |
| Citrate utilization | - | - | + | + | - | - |
| Malonate utilization | - | - | - | - | - | - |
| Hydrolysis of Gelatin | - | - | + | + | - | + |
| Nitrate reduction | + | + | + | + | + | + |
| Salicin | - | - | + | + | - | - |
| VP test | - | - | + | + | - | - |
| ONPG | - | - | - | - | - | - |
| Glucose | + | + | + | + | + | + |
| Mannitol | - | - | + | + | - | - |
| Xylose | - | - | + | + | - | - |
| Inositol | - | + | - | - | - | - |
| Sorbitol | - | - | + | + | - | - |
| Rhamnose | - | ND | - | ND | - | - |
| Sucrose | - | - | + | + | - | - |
| Lactose | - | - | + | + | - | - |
| Arabinose | - | - | + | + | - | - |
| Adonitol | - | ND | - | ND | - | ND |
| Raffinose | - | ND | - | + | - | ND |
+, positive; -, negative; ND: data not described in Bergey's Manual of Systematic Bacteriology [32]; P. spongiae, B. subtilis and P. ganghwense type strains were compiled from Bergey' Manual [32].
Fig 2Phylogenetic trees based on 16S rRNA (a) and gyrB (b) sequences of different strains. The trees were constructed using the neighborjoining (NJ) algorithm in MEGA 7.0. Confidence for the tree topology was estimated using the bootstrap values based on 1000 replicates. Scale bar = 0.05 (or 0.02) substitutions per nucleotide position. The estimated genetic distance between sequences is proportional to the lengths of the horizontal lines connecting one sequence to another.
Sensitivity of strain HL11 to various antibiotics.
| Antibiotics | Concentration (μg/disk) | Sensitivity | Antibiotics | Concentration (μg/disk) | Sensitivity |
|---|---|---|---|---|---|
| Ampicillin | 10 | S | Ciprofloxacin | 5 | I |
| Aztreonam | 30 | S | Norfloxacin | 10 | I |
| Cefepime | 30 | S | Ofloxacin | 5 | I |
| Cefotaxime | 30 | S | Amikacin | 30 | R |
| Ceftazidime | 30 | S | Cefazolin | 30 | R |
| Ceftriaxone | 30 | S | Clarithromycin | 15 | R |
| Cefuroxime | 30 | S | Clindamycin | 2 | R |
| Chloromycetin | 30 | S | Cotrimoxazole | 23.25 | R |
| Levofloxacin | 5 | S | Erythromycin | 15 | R |
| Midecamycin | 30 | S | Gentamycin | 10 | R |
| Nitrofurantoin | 300 | S | Minocycline | 30 | R |
| Piperacillin | 5 | S | Oxacillin | 1 | R |
| Spectinomycin | 100 | S | Penicillin G | 10 | R |
| Cefoperazone | 30 | I | Tetracycline | 30 | R |
| Cefoxitin | 30 | I | Streptomycin | 10 | R |
| Cephalothin | 30 | I | Tobramycin | 10 | R |
S, sensitive; I, intermediate; R, resistant.
Antibacterial activity of different bioactive agents against the strain HL11.
| Bioactive agents | Concentration (mg/L) | Radius of the inhibition zone (mm) | Bioactive agents | Concentration (mg/L) | Radius of the inhibition zone (mm) |
|---|---|---|---|---|---|
| Tea polyphenol | 100 | 20.5±1 | Polylysine | 100 | 21.0±1 |
| 50 | 17.0±1 | 50 | 16.0±1 | ||
| 25 | 14.5±1 | 25 | 14.5±1 | ||
| 12.5 | 12±0.5 | 12.5 | 13±0.5 | ||
| Lactic acid | 100 | 20.0±1 | Allicin | 100 | 18.0±1 |
| 50 | 16.5±1 | 50 | 14.0±1 | ||
| 25 | 14.5±1 | 25 | 12.5±1 | ||
| 12.5 | 11±0.5 | 12.5 | 10.5±0.5 | ||
| Gallic acid | 30 | 19.0±1 | Ampicillin | 100 | 22.0±1 |
| 15 | 15.0±1 | 50 | 18.0±1 | ||
| 10 | 13.5±1 | 25 | 15±1 | ||
| 5 | 0 | 12.5 | 13.5±1 | ||
| Sterile distilled water | 0 | 0 |
Values are means ± SD resulting from at least three independent experiments performed in triplicate.